Skip to content

Effect of Resveratrol , Melatonin and Inositols in childless Women

Comparative Study to Evaluate the Effect of Resveratrol , Melatonin and Inositols on Hormonal Profile, Ovarian Morphology and Endometrial Receptivity in PCOS Infertile Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049569
Enrollment
123
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Melatonin: 6 mg once daily For 3 months Control Intervention1: Resveratrol: 1000mg daily For 3 months

Sponsors

TMMC and RC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Infertile PCOS patients

Exclusion criteria

Exclusion criteria: Thyroid disorder Hyperprolactinemia Diabetes Mellitus Tubal Factor infertility Other Uterine Pathology

Design outcomes

Primary

MeasureTime frame
Metabolic parameters Hormonal profile Ovarian morphology Timepoint: before theray and after 3 months

Secondary

MeasureTime frame
Endometrial receptivityTimepoint: 3 months

Countries

India

Contacts

Public ContactKanchan Rani

TMMCRC

drkanchanrani@gmail.com09756216630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026